Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Agreement Includes Global Rights for Risuteganib, An Investigational Treatment Expected to Help Reverse Vision Loss Due to Dry AMD, A Significant Unmet Medical Need
LAVAL, QC and SAN JUAN CAPISTRANO, Calif., Sept. 21, 2020 -- (Healthcare Sales & Marketi... Biopharmaceuticals, Ophthalmology, Acquisitions Bausch Health Companies, Bausch & Lomb, Allegro Ophthalmics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news